NASDAQ: SMTI - Sanara MedTech Inc.

Yield per half year: -4.28%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Sanara MedTech Inc.


About Sanara MedTech Inc.

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States.

more details
It also offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

IPO date 2011-02-22
ISIN US79957L1008
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://sanaramedtech.com
Цена ао 29.63
Change price per day: 0% (29.96)
Change price per week: +10.88% (27.02)
Change price per month: -7.5% (32.39)
Change price per 3 month: -7.73% (32.47)
Change price per half year: -4.28% (31.3)
Change price per year: -5.34% (31.65)
Change price per 3 year: +7.19% (27.95)
Change price per 5 year: +199.6% (10)
Change price per year to date: -18.23% (36.64)

Underestimation

Title Value Grade
P/S 4.88 3
P/BV 7.11 1
P/E 0 0
EV/EBITDA -81.07 0
Total: 2.25

Efficiency

Title Value Grade
ROA, % -5.83 0
ROE, % -9.6 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.2329

Debt

Title Value Grade
Debt/EBITDA -2.52 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 450.76 10
Yield Ebitda, % -88.44 0
Yield EPS, % -36.66 0
Total: 3.2



Head Job title Payment Year of birth
Mr. Ronald T. Nixon Executive Chairman & CEO N/A 1956 (69 years)
Mr. Michael D. McNeil CFO & Corporate Secretary 438.68k 1965 (60 years)
Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D. President of Telehealth Services 156k 1970 (55 years)
Mr. Callon Nichols Vice President of Corporate Operations N/A
Mr. Bill Fitzgerald Chief Compliance Officer N/A
Ms. Tricia Matteson Vice President of Marketing N/A
Dr. Rebecca Erin Mcmahon President of Research & Development N/A 1985 (40 years)
Mr. Seth Yon President of Commercial N/A
Mr. Jacob A. Waldrop Chief Operating Officer
Mr. Tyler Palmer Chief Corporate Development & Strategy Officer

Address: United States, Fort Worth. TX, 1200 Summit Avenue - open in Google maps, open in Yandex maps
Website: https://sanaramedtech.com